<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: SkinBioTherapeutics shares fall following widened loss reports	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/skinbiotherapeutics-shares-fall-following-widened-loss-reports/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/skinbiotherapeutics-shares-fall-following-widened-loss-reports/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Wed, 19 Feb 2020 11:18:00 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: SkinBioTherapeutics agree psoriasis treatment deal with Winclove Probiotics BV - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/skinbiotherapeutics-shares-fall-following-widened-loss-reports/#comment-14364</link>

		<dc:creator><![CDATA[SkinBioTherapeutics agree psoriasis treatment deal with Winclove Probiotics BV - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 19 Feb 2020 11:18:00 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=24373#comment-14364</guid>

					<description><![CDATA[[&#8230;] are very excited to help SkinBioTherapeutics develop and bring to market together a new probiotic formulation for such an innovative scientific [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] are very excited to help SkinBioTherapeutics develop and bring to market together a new probiotic formulation for such an innovative scientific [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
